U.S. FDA approves Roche's HPV self-testing kit for early cervical cancer detection.

The U.S. FDA has approved Roche's HPV self-testing kit. The Swiss pharmaceutical company's product helps detect HPV, a significant indicator for early cervical cancer detection. This self-test aims to enhance early intervention and prevention strategies for cervical cancer. The FDA's approval allows for more accessible and convenient screening options for individuals concerned about cervical cancer risks.